Ski, a modulator of wound healing and scar formation in the rat skin and rabbit ear

Journal of Pathology

Volumn 223, Issue 5, 2011, Pages 659-671

  Li, Ping ^a   Liu, Ping ^a   Xiong, Ren Ping ^a   Chen, Xing Yun ^a   Zhao, Yan ^a   Lu, Wei Ping ^a   Liu, Xia ^a,b   Ning, Ya Lei ^a   Yang, Nan ^a   Zhou, Yuan Guo ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Gene therapy; Scarring; Ski; TGF ; Wound healing

Indexed keywords

COLLAGEN; ONCOPROTEIN; SKI PROTEIN; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; EAR; EPITHELIZATION; FEMALE; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GRANULATION TISSUE; HYPERTROPHIC SCAR; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RABBIT; RAT; RNA INTERFERENCE; SCAR FORMATION; SIGNAL TRANSDUCTION; SKIN; SKIN INJURY; WOUND HEALING;

ANIMALS; CICATRIX; CICATRIX, HYPERTROPHIC; COLLAGEN; EAR, EXTERNAL; FEMALE; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; INFLAMMATION MEDIATORS; MALE; PROTO-ONCOGENE PROTEINS; RABBITS; RATS; RATS, WISTAR; RNA INTERFERENCE; SKIN; WOUND HEALING;

EID: 79952559237     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2831     Document Type: Article

References (59)

1. Gurtner GC, Werner S, Barrandon Y, et al. Wound repair and regeneration. Nature 2008; 453: 314-321. (Pubitemid 351693137)
2. Wilgus TA, Ferreira AM, Oberyszyn TM, et al. Regulation of scar formation by vascular endothelial growth factor. Lab Invest 2008; 88: 579-590. (Pubitemid 351733282)
3. Krein PM, Brent YH, Winston W. Growth factor regulation and manipulation in wound repair: to scar or not to scar, that is the question. Expert Opin Therapeut Patents 2001; 11: 1065-1079. (Pubitemid 32633390)
4. Younai S, Venters G, Vu S, et al. Role of growth factors in scar contraction: an in vitro analysis. Ann Plast Surg 1996; 36: 495-501. (Pubitemid 26153884)
5. Ferguson MW, O'Kane S. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Phil Trans R Soc Lond B Biol Sci 2004; 359: 839-850. (Pubitemid 38673751)
6. Reish RG, Eriksson E. Scar treatments: preclinical and clinical studies. J Am Coll Surg 2008; 206: 719-730.
7. Mofikoya BO, Adeyemo WL, Abdus-salam AA. Keloid and hypertrophic scars: a review of recent developments in pathogenesis and management. Nig Q J Hosp Med 2007; 17: 134-139.
8. Leventhal D, Furr M, Reiter D. Treatment of keloids and hypertrophic scars: a meta-analysis and review of the literature. Arch Facial Plast Surg 2006; 8: 362-368. (Pubitemid 44862494)
9. Stojadinovic O, Lee B, Vouthounis C, et al. Novel genomic effects of glucocorticoids in epidermal keratinocytes: inhibition of apoptosis, interferon-γ pathway, and wound healing along with promotion of terminal differentiation. J Biol Chem 2007; 282: 4021-4034. (Pubitemid 47084434)
10. Colwell AS, Longaker MT, Lorenz HP. Mammalian fetal organ regeneration. Adv Biochem Eng Biotechnol 2005; 93: 83-100. (Pubitemid 44617148)
11. Colwell AS, Longaker MT, Lorenz HP. Fetal wound healing. Front Biosci 2003; 8: s1240-1248.
12. Shah M, Foreman DM, Ferguson MW. Neutralising antibody to TGFβ1, 2 reduces cutaneous scarring in adult rodents. J Cell Sci 1994; 107: 1137-1157.
13. Shah M, Foreman DM, Ferguson MW. Neutralisation of TGFβ1 and TGFβ2 or exogenous addition of TGFβ3 to cutaneous rat wounds reduces scarring. J Cell Sci 1995; 108: 985-1002.
14. Ferguson MW, Duncan J, Bond J, et al. Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies. Lancet 2009; 373: 1264-1274.
15. Willis BC, Borok Z. TGFβ-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 2007; 293: L525-534.
16. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGFβ family signalling. Nature 2003; 425: 577-584. (Pubitemid 37280136)
17. Ihn H. Autocrine TGFβ signaling in the pathogenesis of systemic sclerosis. J Dermatol Sci 2008; 49: 103-113.
18. Roberts AB, Tian F, Byfield SD, et al. Smad3 is key to TGFβ-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis. Cytokine Growth Factor Rev 2006; 17: 19-27. (Pubitemid 43117513)
19. Qi SH, Xie JL, Pan S, et al. Effects of asiaticoside on the expression of Smad protein by normal skin fibroblasts and hypertrophic scar fibroblasts. Clin Exp Dermatol 2008; 33: 171-175. (Pubitemid 351197217)
20. Altan ZM, Fenteany G. c-Jun N-terminal kinase regulates lamellipodial protrusion and cell sheet migration during epithelial wound closure by a gene expression-independent mechanism. Biochem Biophys Res Commun 2004; 322: 56-67. (Pubitemid 39093840)
21. Deng M, Chen WL, Takatori A, et al. A role for the mitogen-activated protein kinase kinase kinase 1 in epithelial wound healing. Mol Biol Cell 2006; 17: 3446-3455. (Pubitemid 44156439)
22. Nobes CD. Rho GTPases and cell migration-fibroblast wound healing. Methods Enzymol 2000; 325: 441-449.
23. Tura A, Grisanti S, Petermeier K, et al. The Rho-kinase inhibitor H-1152P suppresses the wound-healing activities of human Tenon's capsule fibroblasts in vitro. Invest Ophthalmol Vis Sci 2007; 48: 2152-2161. (Pubitemid 351261289)
24. Lu L, Saulis AS, Liu WR, et al. The temporal effects of anti-TGFβ1, 2, and 3 monoclonal antibody on wound healing and hypertrophic scar formation. J Am Coll Surg 2005; 201: 391-397. (Pubitemid 41206777)
25. Varga J, Pasche B. Transforming growth factor β as a therapeutic target in systemic sclerosis. Nat Rev Rheumatol 2009; 5: 200-206.
26. Li Y, Turck CM, Teumer JK, et al. Unique sequence, ski, in Sloan-Kettering avian retroviruses with properties of a new cell-derived oncogene. J Virol 1986; 57: 1065-1072. (Pubitemid 16143990)
27. Liu X, Li P, Liu P, et al. The essential role for c-Ski in mediating TGFβ1-induced bi-directional effects on skin fibroblast proliferation through a feedback loop. Biochem J 2008; 409: 289-297.
28. Deheuninck J, Luo K. Ski and SnoN, potent negative regulators of TGFβ signaling. Cell Res 2009; 19: 47-57.
29. Liu X, Zhang E, Li P, et al. Expression and possible mechanism of c-ski, a novel tissue repair-related gene during normal and radiation-impaired wound healing. Wound Repair Regen 2006; 14: 162-171.
30. Liu X, Li P, Chen XY, et al. c-Ski promotes skin fibroblast proliferation but decreases type I collagen: implications for wound healing and scar formation. Clin Exp Dermatol 2010; 35: 417-424.
31. Liu X, Liu JZ, Zhang E, et al. Impaired wound healing after local soft X-ray irradiation in rat skin: time course study of pathology, proliferation, cell cycle, and apoptosis. J Trauma 2005; 59: 682-690. (Pubitemid 43014936)
32. Meuli M, Liu Y, Liggitt D, et al. Efficient gene expression in skin wound sites following local plasmid injection. J Invest Dermatol 2001; 116: 131-135. (Pubitemid 32108763)
33. Kim I, Mogford JE, Witschi C, et al. Inhibition of prolyl 4-hydroxylase reduces scar hypertrophy in a rabbit model of cutaneous scarring. Wound Repair Regen 2003; 11: 368-372. (Pubitemid 37122569)
34. Xie JL, Bian HN, Qi SH, et al. Basic fibroblast growth factor (bFGF) alleviates the scar of the rabbit ear model in wound healing. Wound Repair Regen 2008; 16: 576-581. (Pubitemid 352000323)
35. Kapoor M, Liu S, Shi-wen X, et al. GSK-3β in mouse fibroblasts controls wound healing and fibrosis through an endothelin-1-dependent mechanism. J Clin Invest 2008; 118: 3279-3290.
36. Tong M, Tuk B, Hekking IM, et al. Stimulated neovascularization, inflammation resolution and collagen maturation in healing rat cutaneous wounds by a heparan sulfate glycosaminoglycan mimetic, OTR4120. Wound Repair Regen 2009; 17: 840-852.
37. O'Shaughnessy KD, De La Garza M, Roy NK, et al. Homeostasis of the epidermal barrier layer: a theory of how occlusion reduces hypertrophic scarring. Wound Repair Regen 2009; 17: 700-708.
38. Li P, Xiong RP, Liu P, et al. Approach of transgenic disposition of wound healing models with the naked plasmid pcDNA 3.0 in vivo. J Trauma Surg 2006; 8: 253-256 [in Chinese].
39. Morris DE, Wu L, Zhao LL, et al. Acute and chronic animal models for excessive dermal scarring: quantitative studies. Plast Reconstr Surg 1997; 100: 674-681. (Pubitemid 27381074)
40. Kelemen O, Kollar L. [Current methods of treatment and prevention of pathologic scars]. Magy Seb 2007; 60: 63-70.
41. Jeschke MG, Richter G, Hofstadter F, et al. Non-viral liposomal keratinocyte growth factor (KGF) cDNA gene transfer improves dermal and epidermal regeneration through stimulation of epithelial and mesenchymal factors. Gene Ther 2002; 9: 1065-1074.
42. Steinstraesser L, Hirsch T, Beller J, et al. Transient non-viral cutaneous gene delivery in burn wounds. J Gene Med 2007; 9: 949-955. (Pubitemid 350104409)
43. Hanawa T, Suzuki K, Kawauchi Y, et al. Attenuation of mouse acute colitis by naked hepatocyte growth factor gene transfer into the liver. J Gene Med 2006; 8: 623-635. (Pubitemid 43827255)
44. Branski LK, Pereira CT, Herndon DN, et al. Gene therapy in wound healing: present status and future directions. Gene Ther 2007; 14: 1-10. (Pubitemid 44942860)
45. Callewaert B, Malfait F, Loeys B, et al. Ehlers-Danlos syndromes and Marfan syndrome. Best Pract Res Clin Rheumatol 2008; 22: 165-189. (Pubitemid 351325738)
46. Ha VT, Marshall MK, Elsas LJ, et al. A patient with Ehlers-Danlos syndrome type VI is a compound heterozygote for mutations in the lysyl hydroxylase gene. J Clin Invest 1994; 93: 1716-1721. (Pubitemid 24116413)
47. -/- mice. Nat Genet 2002; 30: 106-109.
48. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999; 341: 738-746. (Pubitemid 29407375)
49. Wolcott RD, Rhoads DD, Dowd SE. Biofilms and chronic wound inflammation. J Wound Care 2008; 17: 333-341.
50. Martin P, Leibovich SJ. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol 2005; 15: 599-607. (Pubitemid 41619424)
51. Pugazhenthi K, Kapoor M, Clarkson AN, et al. Melatonin accelerates the process of wound repair in full-thickness incisional wounds. J Pineal Res 2008; 44: 387-396. (Pubitemid 351533523)
52. Mori R, Shaw TJ, Martin P. Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring. J Exp Med 2008; 205: 43-51. (Pubitemid 351185714)
53. Meng F, Cheng X, Yang L, et al. Accelerated re-epithelialization in Dpr2-deficient mice is associated with enhanced response to TGFβ signaling. J Cell Sci 2008; 121: 2904-2912.
54. Rhett JM, Ghatnekar GS, Palatinus JA, et al. Novel therapies for scar reduction and regenerative healing of skin wounds. Trends Biotechnol 2008; 26: 173-180.
55. van der Veer WM, Bloemen MC, Ulrich MM, et al. Potential cellular and molecular causes of hypertrophic scar formation. Burns 2009; 35: 15-29.
56. Ashcroft GS, Yang X, Glick AB, et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1999; 1: 260-266. (Pubitemid 129495775)
57. Macias-Silva M, Li W, Leu JI, et al. Up-regulated transcriptional repressors SnoN and Ski bind Smad proteins to antagonize transforming growth factor-β signals during liver regeneration. J Biol Chem 2002; 277: 28483-28490. (Pubitemid 41079273)
58. Luo K. Ski and SnoN: negative regulators of TGFβ signaling. Curr Opin Genet Dev 2004; 14: 65-70. (Pubitemid 38167479)
59. Jacob C, Grabner H, Atanasoski S, et al. Expression and localization of Ski determine cell type-specific TGFβ signaling effects on the cell cycle. J Cell Biol 2008; 182: 519-530.